RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Pollack, Chief Medical Officer
Reunion Neuroscience Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uab, Psychiatry and Behavioral Neurology
Birmingham, Alabama, United States
Recruiting - University of Arizona
Tucson, Arizona, United States
Recruiting - Kadima Neuropsychiatry Institute
San Diego, California, United States
Recruiting - Providence Medical Foundation
Santa Rosa, California, United States
Recruiting - University of Colorado
Aurora, Colorado, United States
Recruiting - University of South Florida, Department of Psychiatry and Behavioral Neuroscience
Tampa, Florida, United States
Recruiting - Emory University
Atlanta, Georgia, United States
Recruiting - Hawaii Pacific Neuroscience
Honolulu, Hawaii, United States
Recruiting - Rush University Medical Center
Chicago, Illinois, United States
Recruiting - the University of Kansas Medical Center
Kansas City, Kansas, United States
Recruiting - Lsu Health Shreveport
Shreveport, Louisiana, United States
Recruiting - Sunstone Therapies, Pc
Rockville, Maryland, United States
Recruiting - Sheppard Pratt
Towson, Maryland, United States
Recruiting - Dana Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting - University of Michigan
Ann Arbor, Michigan, United States
Recruiting - Henry Ford Health
Novi, Michigan, United States
Recruiting - University of Nebraska Medical Center
Omaha, Nebraska, United States
Recruiting - University of New Mexico, School of Medicine
Albuquerque, New Mexico, United States
Recruiting - Roswell Park Center Institute
Buffalo, New York, United States
Recruiting - Nyu Langone Center for Psychedelic Medicine
New York, New York, United States
Recruiting - University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Recruiting - Cleveland Clinic
Cleveland, Ohio, United States
Recruiting - the Ohio State University, Department of Psychiatry
Columbus, Ohio, United States
Recruiting - University of Pennsylvania
Philadelphia, Pennsylvania, United States
Recruiting - Alliance for Multispecialty Research Clinical
Knoxville, Tennessee, United States
Recruiting - Dell Medical School, University of Texas at Austin
Austin, Texas, United States
Recruiting - Cedar Clinical Research Inc.
Draper, Utah, United States
Recruiting - Uva Center for Psychiatric Clinical Research
Charlottesville, Virginia, United States
Recruiting - Seattle Neuropsychiatric Treatment Center
Seattle, Washington, United States
Recruiting - University of Wisconsin at Madison
Madison, Wisconsin, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jul 2025
- Primary completion
- 30 Nov 2026
- Completion
- 31 Dec 2026
- Last update posted
- 3 Jun 2026
- Registered enrollment
- 100
- Registry id
- NCT07002034
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.